4ags: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:4ags.jpg|left|200px]]
[[Image:4ags.png|left|200px]]


{{STRUCTURE_4ags|  PDB=4ags  |  SCENE=  }}  
{{STRUCTURE_4ags|  PDB=4ags  |  SCENE=  }}  
Line 5: Line 5:
===Leishmania TDR1 - a unique trimeric glutathione transferase===
===Leishmania TDR1 - a unique trimeric glutathione transferase===


{{ABSTRACT_PUBMED_15056070}}
{{ABSTRACT_PUBMED_22753509}}


==About this Structure==
==About this Structure==
Line 11: Line 11:


==Reference==
==Reference==
<ref group="xtra">PMID:015056070</ref><references group="xtra"/>
<ref group="xtra">PMID:022753509</ref><ref group="xtra">PMID:015056070</ref><references group="xtra"/>
[[Category: Leishmania infantum]]
[[Category: Leishmania infantum]]
[[Category: Coombs, G H.]]
[[Category: Coombs, G H.]]

Revision as of 07:29, 11 July 2012

File:4ags.png

Template:STRUCTURE 4ags

Leishmania TDR1 - a unique trimeric glutathione transferase

Template:ABSTRACT PUBMED 22753509

About this Structure

4ags is a 3 chain structure with sequence from Leishmania infantum. Full crystallographic information is available from OCA.

Reference

  1. Fyfe PK, Westrop GD, Silva AM, Coombs GH, Hunter WN. Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation. Proc Natl Acad Sci U S A. 2012 Jul 2. PMID:22753509 doi:10.1073/pnas.1202593109
  2. Denton H, McGregor JC, Coombs GH. Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. Biochem J. 2004 Jul 15;381(Pt 2):405-12. PMID:15056070 doi:10.1042/BJ20040283

Proteopedia Page Contributors and Editors (what is this?)

OCA